Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Inspired Question · S6W-42630 · Session 6

Whether it will provide an update on what action it is taking to ensure that patients with cholangiocarcinoma can access the genomic testin…

Answered Arranged question: government announcement Asked by Marie McNair SNP Lodged 16 Dec 2025

The question

To ask the Scottish Government whether it will provide an update on what action it is taking to ensure that patients with cholangiocarcinoma can access the genomic testing needed to access Scottish Medicines Consortium approved precision therapies.

The answer

Answered by Jenni Minto on 17 Dec 2025 · 1 day after it was lodged, on time

I am pleased to announce that the Scottish Government will support the initial implementation of much-needed testing for cholangiocarcinoma, with funding to be released in December and reassurance from NHS National Services Division (NSD), the national commissioner of genomic testing in NHS Scotland, that this will be available to patients across Scotland from February 2026.This is a single test for a relatively rare form of cancer. However, I want to assure you that the Scottish Government is fully committed to improving access to the full range of genomic testing needed and to building the foundations required to allow Scotland to take full advantage of developments in genomic medicine, including data and digital infrastructure and skilled workforce requirements. This is part of our long-term approach to deliver bold and ambitious action to reform and renew our health and care systems in Scotland within a fiscal position that remains extremely challenging.

In the Official Report

No contribution in the Official Report cites S6W-42630 by reference.